Skip to content

Effect of Music on Patients in Intensive Care Units

The Effect of Patient-Preferred Music, Relaxation Music, and Standard Care Environment on Patients in Intensive Care Units

Status
Withdrawn
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00823017
Acronym
MTS2
Enrollment
0
Registered
2009-01-15
Start date
2006-07-31
Completion date
2011-03-02
Last updated
2018-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intensive Care Unit

Keywords

ICU environment, Auditory stimulation, Properties of relaxation music, music, music therapy, pain, anxiety, cortisol, IgA, biomarkers, relaxation music

Brief summary

The purpose of this study is to investigate the effects of patient-preferred music, relaxation music, and standard care environment on patients in intensive care units.

Detailed description

This study is a prospective randomized clinical trial. The purpose of this 4-stage study is to explore the effects of patient-preferred music, relaxation music, and standard care environment on patients in intensive care units. Stage 1: Recommendation of relaxation music by music therapists who serves as expert panel Stage 2: Analysis of recommended relaxation music by music therapists Stage 3: Content validation of relaxation music by healthy adults Stage 4: Comparison of patients' physiological, psychological, and biological responses to patient-preferred music, relaxation music, and standard care environment

Interventions

OTHERPatient-preferred music

Music of patients' preference

Relaxation music compiled from results of first three stages of study

OTHERStandard Care Environment

Control, no interventions

Sponsors

The Cleveland Music School Settlement
CollaboratorOTHER
Kulas Foundation
CollaboratorOTHER
Arthur Flagler Fultz Research Award (American Music Therapy Association)
CollaboratorUNKNOWN
MetroHealth Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Communicative (non-intubated, non-sedated) * At least three days of admission (excluding day of admission) * 18 years or older * Mean arterial blood pressure equal or greater than 65 throughout study * Mean SpO2 equal or greater than 90 throughout study * Glasgow coma scale equal or greater than 14 * Bilirubin level less than 5 * Ammonia level less than 1 * Hematocrit level greater than 15 * BUN equal or less than 100 Non-communicative (intubated, sedated) * At least three days of admission (excluding day of admission) * 18 years or older * Mean arterial blood pressure equal or greater than 65 throughout study * Mean SpO2 equal or greater than 90 throughout study * Glasgow coma scale equal or greater than 10 * Bilirubin level less than 5 * Ammonia level less than 1 * Hematocrit level greater than 15 * BUN equal or less than 100

Exclusion criteria

Communicative (non-intubated, non-sedated) * Patients admitted for or less than 3 days * Patients with hearing impairments * Patients with neurological impairments that might impair their ability to process information * Patients on glucocorticoid medications * Patients with mental health diagnoses and currently experiencing active psychosis such as hallucinations and/or delusions * Patient's condition altered dramatically over the 3 days of research Non-communicative (intubated, sedated) * Patients admitted for or less than 3 days * Patients with hearing impairments * Patients with neurological impairments that might impair their ability to process information * Patients on glucocorticoid medications * Patients with mental health diagnoses and currently experiencing active psychosis such as hallucinations and/or delusions * Patient's condition altered dramatically over the 3 days of research

Design outcomes

Primary

MeasureTime frame
Saliva/Serum Immunoglobulin A Concentration3 data points throughout 1-hour intervention
Pain level4 data points throughout 1-hour intervention
Anxiety level4 data points throughout 1-hour intervention
Comfort level4 data points throughout 1-hour intervention
Heart rate4 data points throughout 1-hour intervention
Respiration rate4 data points throughout 1-hour intervention
Blood pressure4 data points throughout 1-hour intervention
Saliva/Serum Cortisol level3 data points throughout 1-hour intervention

Secondary

MeasureTime frame
Psychophysical properties of relaxation music1 rating

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026